1

In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 02-235V

(To be published)

* * * * * * * * * * * * * * * * * * * * * * * * * 

KELLIE MILLER and *

RON MILLER, as mother and father of *

A.H.M., a minor, * Filed: June 3, 2016

*

Petitioners, * 

* Vaccine Act Fees and Costs;

v. * Autism Case; Reasonable Basis

*

SECRETARY OF HEALTH AND *

HUMAN SERVICES * 

* 

Respondent. * 

* * * * * * * * * * * * * * * * * * * * * * * * * 

Michael L. Cave, Cave Law Firm, Baton Rouge, LA, for Petitioners.

Linda Renzi, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING ATTORNEYS’ FEES AND COSTS

HASTINGS, Special Master.

In this case under the National Vaccine Injury Compensation Program (hereinafter “the 

Program”1), Petitioners seek, pursuant to 42 U.S.C. § 300aa-15(e)(1), an award for attorneys’ 

fees and other costs incurred in attempting to obtain Program compensation. They seek a total 

award of $63,669. After careful consideration, I have decided to grant the request in part, but to 

deny most of the request, because it was not reasonable for Petitioners to take to trial their very 

weak case contending that A.H.M.’s autism spectrum disorder was vaccine-related. 

 

1 The applicable statutory provisions defining the Program are found at 42 U.S.C. § 300aa10 et seq. (2012 ed.). Hereinafter, for ease of citation, all "§" references will be to 42 U.S.C. 

(2012 ed.). The statutory provisions defining the Program are also sometimes referred to as the 

“Vaccine Act.” 
2

I

BACKGROUND LAW CONCERNING ATTORNEYS’ FEES AND COSTS AWARDS

A. General

Special masters have the authority to award “reasonable” attorneys' fees and litigation

costs in Vaccine Act cases. §300aa–15(e)(1). This is true even when a petitioner is unsuccessful 

on the merits of the case -- in such cases, a special master “may” award fees, if the petition was 

filed in good faith and with a reasonable basis. Id. “The determination of the amount of 

reasonable attorneys' fees is within the special master's discretion.” Saxton v. HHS, 3 F.3d 1517, 

1520 (Fed. Cir. 1993); see also Shaw v. HHS, 609 F.3d 1372, 1377 (Fed. Cir. 2010).

Further, as to all aspects of a claim for attorneys' fees and costs, the burden is on the 

petitioner to demonstrate that the attorneys' fees claimed are “reasonable.” Sabella v. HHS, 86 

Fed. Cl. 201, 215 (2009); Hensley v. Eckerhart, 461 U.S. 424, 437 (1983); Rupert v. HHS, 52 

Fed. Cl. 684, 686 (2002); Wilcox v. HHS, No. 90–991V, 1997 WL 101572, at *4 (Fed. Cl. Spec. 

Mstr. Feb. 14, 1997). The petitioner's burden of proof to demonstrate “reasonableness” applies 

equally to costs as well as attorneys' fees. Perreira v. HHS, 27 Fed. Cl. 29, 34 (1992), aff'd, 33 

F.3d 1375 (Fed. Cir. 1994).

One test of the “reasonableness” of a fee or cost item is whether a hypothetical petitioner, 

who had to use his own resources to pay his attorney for Vaccine Act representation, would be 

willing to pay for such expenditure. Riggins v. HHS, No. 99–382V, 2009 WL 3319818, at *3 

(Fed. Cl. Spec. Mstr. June 15, 2009), aff'd by unpublished order (Fed. Cl. Dec. 10, 2009), aff’d,

406 Fed. App’x. 479 (Fed. Cir. 2011); Sabella v. HHS, No. 02–1627V, 2008 WL 4426040, at 

*28 (Fed. Cl. Spec. Mstr. Aug. 29, 2008), aff'd in part and rev'd in part, 86 Fed. Cl. 201 (2009). 

In this regard, the United States Court of Appeals for the Federal Circuit has noted that:

[i]n the private sector, ‘billing judgment’ is an important component in fee setting. It is 

no less important here. Hours that are not properly billed to one's client also are not 

properly billed to one's adversary pursuant to statutory authority.

Saxton, 3 F.3d at 1521 (emphasis in original) (quoting Hensley, 461 U.S. at 433–34). Therefore, 

in assessing the number of hours reasonably expended by an attorney, the court must exclude 

those “hours that are excessive, redundant, or otherwise unnecessary, just as a lawyer in private 

practice ethically is obligated to exclude such hours from his fee submission.” Hensley, 461 U.S. 

at 434; see also Riggins, 2009 WL 3319818, at *4.

The Federal Circuit has also made clear that special masters may rely on their prior 

experience in making reasonable fee determinations, without conducting a line-by-line analysis 

of the fee bill, and are not required to rely on specific objections raised by respondent. See 

Saxton, 3 F.3d at 1521; Sabella, 86 Fed. Cl. 201, 209 (2009); see also Wasson v. HHS, 24 Cl. Ct. 

482, 484, 486 (1991), aff’d, 988 F.2d 131 (Fed. Cir. 1993) (holding that, in determining a 

reasonable number of hours expended in any given case, a special master may rely on her 

experience with the Vaccine Act and its attorneys, without basing his decision on a line-by-line 
3

examination of the fee application). A unanimous Supreme Court has articulated a similar 

holding:

We emphasize, as we have before, that the determination of fees “should not result in a 

second major litigation.” The fee applicant (whether a plaintiff or a defendant) must, of 

course, submit appropriate documentation to meet “the burden of establishing entitlement 

to an award.” But trial courts need not, and indeed should not, become green-eyeshade 

accountants. The essential goal in shifting fees (to either party) is to do rough justice, not 

to achieve auditing perfection. So trial courts may take into account their overall sense of 

a suit, and may use estimates in calculating and allocating an attorney’s time. And 

appellate courts must give substantial deference to these determinations, in light of “the 

district court’s superior understanding of the litigation.” We can hardly think of a sphere 

of judicial decisionmaking in which appellate micromanagement has less to recommend 

it.

Fox v. Vice, 563 U.S. 826, 838 (2011) (internal citations omitted).

B. Reasonable basis

The statute and legislative history afford no guidance as to the precise meaning of 

“reasonable basis,” and the case law is relatively scant. The Chief Judge of this Court has 

explained that not all claims should be found to have a reasonable basis, and that whether a 

reasonable basis exists is determined by the “totality of the circumstances.” Chuisano v. HHS, 

116 Fed. Cl. 276, 285-286 (2014). A special master has “discretion” in determining whether a 

reasonable basis existed. Murphy v. HHS, 30 Fed. Cl. 60, 61 (1993), aff’d without opinion, 48 

F.3d 1236 (1995) (judge affirmed a denial of reasonable basis, noting that the determination 

concerning reasonable basis is reviewed under an “abuse of discretion” standard). In other cases 

in which, as in Murphy, a judge affirmed a denial of reasonable basis, the court remarked that the 

special master’s discretion is “wide” (Perreira v. HHS, 27 Fed. Cl. 29, 34 (1992)), and “very 

broad” (Silva v. HHS, 108 Fed. Cl. 401, 405 (2012)). In fact, in Silva, the court remarked that it 

is “difficult to imagine a broader grant of authority and discretion.” 108 Fed. Cl. at 405. 

The only opinion of the United States Court of Appeals for the Federal Circuit, 

discussing the “reasonable basis” requirement in a Vaccine Act case, is Perreira v. HHS, 33 F. 

3d 1375 (Fed. Cir. 1994). In Perreira, the special master concluded that the petitioners had a 

reasonable basis for initially filing the case and for the first part of their prosecution of the case, 

but concluded that there was no reasonable basis for pursuing the case beyond the point when 

the Perreiras submitted an expert report, at which time the Perreiras’ attorneys should have 

realized that their expert’s theory was plainly deficient to demonstrate causation. 33 F.3d at 

1376. The special master denied fees and costs for work performed after that point, in taking the 

case to an evidentiary hearing. Id. Both the Court of Federal Claims (27 Fed. Cl. 29 (1992)),

and the Federal Circuit (33 F.3d at 1376-77) affirmed. 

The Court of Federal Claims judge rejected the Perreiras’ argument that they 

automatically passed the “reasonable basis” test because they were relying on an expert’s report, 

finding that argument to be “unreasonable.” 27 Fed. Cl. at 33-34. The judge found that under all 

the circumstances of the case, for the petitioners to take the case to an evidentiary hearing “with 
4

no support in the contemporaneous medical records,” and with no “reputable medical opinion or 

scientific studies” (emphasis added) was also “unreasonable.” Id. at 34. 

The Federal Circuit agreed with the court below, observing that “counsel’s duty to 

zealously represent their client does not relieve them of their duty to the court to avoid frivolous 

litigation.” 33 F.3d. at 1377. The appellate court added that Congress did not intend that every 

claimant qualify for an attorneys’ fee award “by merely having an expert state an unsupported 

opinion that the vaccine was the cause in-fact of the injury.” Id. The court concluded that the 

special master did not err in determining that the Perreiras “no longer had a reasonable basis for 

claiming causation in-fact” after their expert report was filed. Id. 

 

 II

BACKGROUND: THE OMNIBUS AUTISM PROCEEDING (“OAP”)

This case is one of more than 5,400 cases filed under the Program in which petitioners 

alleged that conditions known as “autism” or “autism spectrum disorders” (“ASD”)2 were caused 

by one or more vaccinations. A special proceeding known as the Omnibus Autism Proceeding 

(“OAP”) was developed to manage these cases within the Office of Special Masters (“OSM”). A 

detailed history of the controversy regarding vaccines and autism, along with a history of the 

development of the OAP, was set forth in the six entitlement decisions issued as “test cases” for 

two theories of causation litigated in the OAP (see cases cited below), and will only be 

summarized here. 

A group called the Petitioners’ Steering Committee (“PSC”) was formed in 2002 by the 

many attorneys who represented Vaccine Act petitioners who raised autism-related claims. 

About 180 attorneys participated in the PSC. Their responsibility was to develop any available 

evidence indicating that vaccines could contribute to causing autism, and eventually present that 

evidence in a series of “test cases,” exploring the issue of whether vaccines could cause autism, 

and, if so, in what circumstances. Ultimately, the PSC selected groups of attorneys to present 

evidence in two different sets of “test cases” during many weeks of trial in 2007 and 2008. In 

 

2

“Autism Spectrum Disorder” is a general classification which as of 2010 included five 

different specific disorders: Autistic Disorder, Childhood Disintegrative Disorder, Asperger’s 

Syndrome, Rett Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified 

(PDD-NOS). King v. HHS, No. 03-584V, 2009 WL 892296 at *5 (Fed. Cl. Spec. Mstr. Feb. 12, 

2010). The term “autism” is often utilized to encompass all of the types of disorders falling 

within the autism spectrum. (Id.) I recognize that since the OAP test cases, the consensus 

description of ASDs, contained now in the “DSM-V” as opposed to the prior “DSM-IV,” revises 

the prior subcategories of ASD set forth in the first sentence of this footnote. However, the 

DSM-V retains the same general description of ASDs. An ASD is a serious form of 

neurodevelopmental disorder defined by a collection of symptoms and behaviors, including 

significant impairment of social interaction and language skills, and the presence of repetitive, 

stereotyped interests. E.g., Snyder v. HHS, No. 01-162V, 2009 WL 332044, at *31 (Fed. Cl. 

Spec. Mstr. Feb. 12, 2009). 
5

the six test cases, the PSC presented two separate theories concerning the causation of ASDs. 

The first theory alleged that the measles portion of the measles, mumps, rubella (“MMR”) 

vaccine could cause ASDs. That theory was presented in three separate Program test cases 

during several weeks of trial in 2007. The second theory alleged that the mercury contained in 

thimerosal-containing vaccines could directly affect an infant’s brain, thereby substantially 

contributing to the causation of ASD. That theory was presented in three additional test cases 

during several weeks of trial in 2008.

Decisions in each of the three test cases pertaining to the PSC’s first theory rejected the 

petitioners’ causation theories. Cedillo v. HHS, No. 98-916V, 2009 WL 331968 (Fed. Cl. Spec. 

Mstr. Feb. 12, 2009) aff’d, 89 Fed. Cl. 158 (2009), aff’d, 617 F.3d 1328 (Fed. Cir. 2010); 

Hazlehurst v. HHS, No. 03-654V, 2009 WL 332306 (Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d

88 Fed. Cl. 473 (2009), aff’d, 604 F.3d 1343 (Fed. Cir. 2010); Snyder v. HHS, No. 01-162V, 

2009 WL 332044 (Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d, 88 Fed. Cl. 706 (2009).3 Decisions 

in each of the three “test cases” pertaining to the PSC’s second theory also rejected the 

petitioners’ causation theories, and the petitioners in each of those three cases chose not to 

appeal. Dwyer v. HHS, No. 03-1202V, 2010 WL 892250 (Fed. Cl. Spec. Mstr. Mar. 12, 2010); 

King v. HHS, No. 03-584V, 2010 WL 892296 (Fed. Cl. Spec. Mstr. Mar 12, 2010); Mead v. 

HHS, No. 03-215V, 2010 WL 892248 (Fed. Cl. Spec. Mstr. Mar. 12, 2010). 

The “test case” decisions were comprehensive, analyzing in detail all of the evidence 

presented on both sides. The three test case decisions concerning the PSC’s first theory 

(concerning the MMR vaccine) totaled more than 600 pages of detailed analysis, and were 

solidly affirmed in many more pages of analysis in three different rulings by three different 

judges of the United States Court of Federal Claims, and in two rulings by two separate panels of 

the United States Court of Appeals for the Federal Circuit. The three special master decisions 

concerning the PSC’s second theory (concerning vaccinations containing the preservative 

“thimerosal”) were similarly comprehensive.

All told, the 11 lengthy written rulings by the special masters, the judges of the U.S. 

Court of Federal Claims, and the panels of the U.S. Court of Appeals for the Federal Circuit 

unanimously rejected the petitioners’ claims, finding no persuasive evidence that either the 

MMR vaccine or thimerosal-containing vaccines could contribute in any way to the causation of 

autism.

Thus, the proceedings in the six “test cases” concluded in 2010. Thereafter, the 

Petitioners in this case, and the petitioners in other cases within the OAP, were instructed to 

decide how to proceed with their own claims. The vast majority of those autism petitioners 

elected either to withdraw their claims, or to request that the special master file a decision 

denying their claim on the written record, resulting in a decision rejecting the petitioner’s claim 

for lack of support. However, a small minority of the autism petitioners have elected to continue 

to pursue their cases, seeking other causation theories and/or other expert witnesses. A number 

of such cases have gone to trial before a special master, and in the cases of this type decided thus 

far, all have resulted in rejection of petitioners’ claims that vaccines played a role in causing 

their child’s autism. See, e.g., Henderson v. HHS, No. 09-616V, 2012 WL 5194060 (Fed. Cl. 

Spec. Mstr. Vowell Sept. 28, 2012) (autism not caused by pneumococcal vaccination); Franklin 

 

3 The petitioners in Snyder did not appeal the decision of the U.S. Court of Federal Claims.
6

v. HHS, No. 99-855V, 2013 WL 3755954 (Fed. Cl. Spec. Mstr. Hastings May 16, 2013) (MMR 

and other vaccines found not to contribute to autism); Coombs v. HHS, No. 08-818V, 2014 WL 

1677584 (Fed. Cl. Spec. Mstr. Hastings Apr. 8, 2014) (autism not caused by MMR or Varivax 

vaccines); Long v. HHS, No. 08-792V, 2015 WL 1011740 (Fed. Cl. Spec. Mstr. Hastings Feb. 

19, 2015) (autism not caused by influenza vaccine); Brook v. HHS, No. 04-405V, 2015 WL 

3799646 (Fed. Cl. Spec. Mstr. Hastings May 14, 2015) (autism not caused by MMR or Varivax 

vaccines); Holt v. HHS, No. 05-136V, 2015 WL 4381588 (Fed. Cl. Spec. Mstr. Vowell June 24, 

2015) (autism not caused by hepatitis B vaccine); Lehner v. HHS, No. 08-554V, 2015 WL 

5443461 (Fed. Cl. Spec. Mstr. Vowell July 22, 2015) (autism not caused by influenza vaccine); 

Miller v. HHS, No. 02-235V, 2015 WL 5456093 (Fed. Cl. Spec. Mstr. Vowell August 18, 2015) 

(ASD not caused by combination of vaccines); Allen v HHS, No. 02-1237V, 2015 WL 6160215 

(Fed. Cl. Spec. Mstr. Vowell Sept. 26, 2015) (autism not caused by MMR vaccination); R.K. v. 

HHS, No. 03-632V (Fed. Cl. Spec. Mstr. Vowell Sept. 28, 2015) (autism not caused by influenza 

vaccine) (not yet published), aff’d 2016 WL 552481 (Fed. Cl. J. Braden Feb. 12, 2016); Hardy v. 

HHS, No. 08-108V, 2015 WL 7732603 (Fed. Cl. Spec. Mstr. Hastings Nov. 3, 2015) (autism not 

caused by several vaccines); Sturdivant v. HHS, No. 07-788V, 2016 WL 552529 (Fed. Cl. Spec. 

Mstr. Hastings Jan. 21, 2016) (autism not caused by Hib and Prevnar vaccines); Vernacchio v. 

HHS, No. 08-504 (Fed. Cl. Spec. Mstr. Corcoran Feb. 19, 2016) (autism not caused by influenza 

vaccine) (not yet published); Murphy v. HHS, No. 05-1063V (Fed. Cl. Spec. Mstr. Corcoran 

April 25, 2016) (autism not caused by DTaP or MMR vaccines) (not yet published).

In addition, some autism causation claims have been rejected without trial, at times over 

the petitioner’s objection, in light of the failure of the petitioner to file plausible proof of 

vaccine-causation. See, e.g., Waddell v. HHS, No. 10-316V, 2012 WL 4829291 (Fed. Cl. Spec. 

Mstr. Campbell-Smith Sept. 19, 2012) (autism not caused by MMR vaccination); Fester v. HHS, 

No. 10-243V, 2016 WL 1745436 (Fed. Cl. Spec. Mstr. Dorsey April 7, 2016) (autism not caused 

by measles, mumps, rubella, and varicella (MMRV) vaccine); Fresco v. HHS, No. 06-469V, 

2013 WL 364723 (Fed. Cl. Spec. Mstr. Vowell Jan. 7, 2013) (autism not caused by multiple 

vaccines); Fesanco v. HHS, No. 02-1770, 2010 WL 4955721 (Fed. Cl. Spec. Mstr. Hastings 

Nov. 9, 2010) (autism not caused by multiple vaccines); Miller v. HHS, No. 06-753V, 2012 WL 

12507077 (Fed. Cl. Spec. Mstr. Hastings Sept. 25, 2012) (autism not caused by DTaP or MMR 

vaccines); Blake v. HHS, No. 03-31V, 2014 WL 2769979 (Fed. Cl. Spec. Mstr. Vowell May 21, 

2014) (autism not caused by MMR vaccination); Pietrucha v. HHS, No. 00-269V, 2014 WL 

4538058 (Fed. Cl. Spec. Mstr. Hastings Aug. 22, 2014) (autism not caused by multiple 

vaccines); Bushnell v. HHS, No. 02-1648, 2015 WL 4099824 (Fed. Cl. Spec. Mstr. Hastings June 

12, 2015) (autism not caused by multiple vaccines); Bokmuller v. HHS, No. 08-573, 2015 WL 

4467162 (Fed. Cl. Spec. Mstr. Hastings June 26, 2015) (autism not caused by multiple vaccines); 

Canuto v. HHS, No. 04-1128, 2015 WL 9854939 (Fed. Cl. Spec. Mstr. Hastings Dec. 18, 2015) 

(autism not caused by DTP and DTaP vaccines); Valle v. HHS, No. 02-220V, 2016 WL 2604782 

(Fed. Cl. Spec. Mstr. Hastings April 13, 2016) (autism not caused by DTaP vaccine). Judges of 

this court have affirmed the practice of dismissal without trial in such cases. E.g., Fesanco v. 

HHS, 99 Fed. Cl. 28 (2011) (Judge Braden affirming); Canuto v. HHS (filed 4-18-16) (Judge 

Yock affirming).
7

In none of the rulings since the test cases has a special master or judge found any merit in 

an allegation that any vaccine can contribute to causing autism.4

III

PROCEDURAL HISTORY5

The Petitioners, Kellie Miller and Ron Miller, filed this petition on March 26, 2002, 

alleging that their minor daughter, A.H.M., was injured by several vaccinations. (Petition, ECF 

 

4

I am well aware, of course, that during the years since the “test cases” were decided, in 

two cases involving vaccinees suffering from ASDs, Vaccine Act compensation was granted. 

But in neither of those cases did the Respondent concede, nor did a special master find, that there 

was any “causation-in-fact” connection between a vaccination and the vaccinee’s ASD. Instead, 

in both cases it was conceded or found that the vaccinee displayed the symptoms of a Table 

Injury within the Table time frame after vaccination. (See §300aa-11(c)(1)(C)(i); §300aa-14.) 

In Poling v. HHS, the presiding special master clarified that the family was compensated 

because the Respondent conceded that the Poling child had suffered a Table Injury--not because 

the Respondent or the special master had concluded that any vaccination had contributed to 

causing or aggravating the child’s ASD. See Poling v. HHS, No. 02-1466V, 2011 WL 678559, 

at *1 (Fed. Cir Spec. Mstr. Jan. 28, 2011) (a fees decision, but noting specifically that the case 

was compensated as a Table Injury). 

Second, in Wright v. HHS, No. 12-423, 2015 WL 6665600 (Fed. Cl. Spec. Mstr. Sept. 21, 

2015), Special Master Vowell concluded that a child, later diagnosed with ASD, suffered a 

“Table Injury” after a vaccination. However, she stressed that she was not finding that the 

vaccinee’s ASD in that case was “caused-in-fact” by the vaccination--to the contrary, she 

specifically found that the evidence in that case did not support a “causation-in-fact” claim, 

going so far as to remark that the petitioners’ “causation-in-fact” theory in that case was 

“absurd.” Wright v. HHS, No. 12-423, 2015 WL 6665600, at *2 (Fed. Cl. Spec. Mstr. Sept. 21, 

2015).

The compensation of these two cases, thus, does not afford any support to the notion that 

vaccinations can contribute to the causation of autism. In setting up the Vaccine Act 

compensation system, Congress forthrightly acknowledged that the Table Injury presumptions 

would result in compensation for some injuries that were not, in fact, truly vaccine-caused. H.R. 

Rept. No. 99-908, 18, 1986 U.S.C.C.A.N. 6344, 6359. (“The Committee recognizes that there is 

public debate over the incidence of illnesses that coincidentally occur within a short time of 

vaccination. The Committee further recognizes that the deeming of a vaccine-relatedness 

adopted here may provide compensation to some children whose illness is not, in fact, vaccinerelated.”)

5 A more detailed procedural history of this case was presented in Chief Special Master 

Vowell’s Decision denying compensation in this case. See 2015 WL 5456093, at *1-6. Here I 

lay out only those details relevant to this Decision. 
8

No. 1.) Because this case involved a child who suffered from an autism spectrum disorder 

(ASD), proceedings in the case, as explained in Section II of this Decision above, were stayed 

until the outcomes of the OAP “test cases” became final. On March 22, 2007, the case was 

assigned to Special Master Denise Vowell. 

In April 2011, after the final appellate decision in the OAP test cases was issued, 

Petitioners were ordered to inform the special master whether they intended to proceed with their 

claim, either on a new theory of causation or with new evidence on one or both of the rejected 

causation theories. (Order, issued Apr. 29, 2011.) On July 18, 2011, Petitioners filed an 

amended petition, which claimed that the varicella vaccination received on June 4, 1999, was a 

causal vaccination, in addition to the vaccinations received on September 15, 1999. (ECF No. 

27.)

However, Special Master Vowell found that the --

filed medical records did not establish the diagnosis of a mitochondrial dysfunction 

claimed in the amended petition, and [an] affidavit of Dr. Amy Holmes, a treating 

physician, filed with the original petition in 2002 as Pet. Ex. 7, was inadequate to 

establish vaccine causation.

2015 WL 5456093, at *4. The special master expressed these views in an Order filed on July 28, 

2011. (ECF No. 28.) 

On December 1, 2011, Petitioners’ attorney, Michael L. Cave, filed the expert report of 

his mother, Dr. Stephanie Cave, in support of Petitioners’ causation claim. (ECF No. 34.) 

Special Master Vowell immediately expressed to Mr. Cave her doubts about Dr. Cave’s report, 

filing an Order containing a lengthy list of “significant problems” with the report substantively, 

and ordered Mr. Cave to file a supplemental report of Dr. Cave, or the report of a different 

expert, curing the defects. (Order, issued Dec. 6, 2011, ECF No. 35.) In that same order, Special 

Master Vowell indicated concerns about the familial relationship between Dr. Cave and Mr. 

Cave, noting that such relationship could make payment of expert fees “problematic.” (ECF No. 

35, p. 2, fn. 3.) 

Petitioners filed a supplemental report from Dr. Cave on January 23, 2012, and chose to 

keep Dr. Cave as their testifying expert in this case. Special Master Vowell noted that during the 

last four years before her Decision was filed, Petitioners --

modified their claim repeatedly, raising new theories and re-litigating old ones, but *** 

failed to produce reliable evidence that any vaccine or combination of vaccines that 

A.H.M. received actually caused her condition. 

2015 WL 5456093 at *1. 

An evidentiary hearing was held on May 10, 2013, in which Dr. Cave was the sole expert 

for Petitioners, and Dr. Max Wiznitzer, a pediatric neurologist, testified for Respondent. 

On August 18, 2015, Special Master Vowell filed her Decision denying Petitioners’ claim 

for Program compensation. (ECF No. 79.) That decision will be discussed in detail in Section 
9

IV of this Decision below. Petitioners did not seek review of that Decision, so that judgement 

denying their claim was entered on September 18, 2015. (ECF No. 83.) 

Due to Special Master Vowell’s imminent retirement, the case was reassigned to my 

docket on August 21, 2015. (ECF No. 81.) 

On March 7, 2016, Petitioners filed an application seeking attorneys’ fees and costs 

incurred in their attempt to gain compensation in this proceeding. (ECF No. 84.) They seek a 

total of $63,668.82 in fees and costs. Respondent filed a short Response on March 23, 2016, 

arguing generally that I should award a reduced amount, but offering no substantial analysis of 

the application. (ECF No. 85.) The Respondent takes the position that the Vaccine Act does not 

contemplate a “role for Respondent in the resolution of a request by a petitioner for an award of 

attorneys’ fees and costs,” (id., p. 1), and requests that the special master “exercise his 

discretion” in determining a reasonable award (id., p. 4). 

IV

SPECIAL MASTER VOWELL’S DECISION

Special Master Vowell rejected the Petitioners’ claim in a Decision filed on August 18, 

2015. Although the special master provided a lengthy discussion of why she denied the 

Petitioners’ claim, I will highlight a few of her points here. 

A. General deficiencies in Dr. Cave’s qualifications and Petitioners’ presentation

Special Master Vowell found that, in general, Dr. Cave’s and Mr. Cave’s presentations 

were poorly developed and quite unpersuasive. She summarized that --

Petitioners’ hearing presentation and post-hearing arguments were not well-developed or 

presented. In spite of my cautions during several status conferences and in orders that I 

did not intend to permit re-litigation of the rejected OAP test case theories, absent new 

evidence, Dr. Cave presented testimony about mercury, oxidative stress, and brain 

inflammation that had been heard and rejected in the OAP test cases, without producing 

any new evidence. The presentation of their new mitochondrial disorder theory was 

highly speculative, poorly explained by Dr. Cave, and did not fit the facts of petitioners’ 

case. 

2015 WL 5456093, at *7 (footnote omitted). In her discussion, Special Master Vowell 

emphasized that --

Dr. Wiznitzer’s qualifications to opine on the causes of ASD and whether A.H.M. has 

ASD, or a mitochondrial dysfunction masquerading as ASD, far exceed those of Dr. 

Cave. Doctor Wiznitzer is more highly credentialed in relevant areas such as pediatrics 

and neurology than Dr. Cave. 

2015 WL 5456093, at *11. The special master noted that while Dr. Cave is board-certified in 

family medicine, Dr. Cave was severely underqualified to testify in the specialized area 

concerning the causation of ASDs. 2015 WL 5456093, at *8. Special Master Vowell stated that
10

Despite her lack of training, research, or board certification in relevant disciplines, Dr. 

Cave opined on a range of medical conditions, but offered little support for her opinions,

*** [and gave] sweeping statements about causation (see, e.g., Tr. at 70-71) and opinions 

in areas in which she has neither the training nor the experience to opine credibly. 

Id., at *11. The special master summarized that Dr. Cave had “poor qualifications to opine as an 

expert” in this case. Id. at *12. 

B. Dr. Cave’s and Mr. Cave’s misreading and/or disregard of the medical records

One significant aspect of Special Master Vowell’s reasoning in rejecting Petitioners’ 

claim was that --

after reviewing the entire record and weighing the experts’ testimony, I conclude that the 

symptoms and behaviors that Dr. Cave relied upon for her conclusion that A.H.M. 

regressed did not occur as she described them. 

2015 WL 5456093, at *24. For example, regarding Dr. Cave’s assertion that A.H.M. 

experienced a “sudden” or “dramatic” reaction to either his June 1999 or September 1999 

vaccinations, Special Master Vowell found that assertion to be incorrect. Id. at *25. She found 

that that statement by Dr. Cave was inconsistent with the contemporaneous medical records. Id. 

She also found that Dr. Cave’s assertion that A.H.M. experienced a sharp increase in illnesses 

after the September vaccination was also inconsistent with the contemporaneous medical 

records. Id. The Special Master further found that Dr. Cave’s testimony about A.H.M.’s 

language “demonstrated a lack of familiarity with and a selective reading of the information 

contained in A.H.M.’s records.” Id. at *26. She also observed that “Doctor Cave’s assertions 

about a developmental regression were based on a selective reading of the medical records.” Id. 

at *27.

In short, Special Master Vowell criticized both Dr. Cave and Mr. Cave for basing their 

allegations of vaccine-caused injury upon a major distortion of the facts of A.H.M.’s case. She 

stated that “Petitioners’ assertions regarding the factual predicate for their claims are so far 

removed from the facts of this case that I could deny petitioners’ claims on that basis alone.” 

2015 WL 5456093, at *37. 

C. Dr. Cave’s confused and incorrect testimony concerning an alleged “mitochondrial 

disorder” 

One major difference between the opposing experts was whether A.H.M. suffered from a 

mitochondrial disorder, as Dr. Cave asserted. On this point, Special Master Vowell stated that 

“[n]o treating physician or specialist ever diagnosed A.H.M. with a mitochondrial disorder, 

mitochondrial disease, or mitochondrial dysfunction.” 2015 WL 5456093 at *28. The special 

master engaged in a lengthy analysis of the “Morava Criteria” for identifying the existence of a 

mitochondrial disorder (id. at 30-34), and found that Dr. Cave’s attempt to use those criteria 

“reflected a fundamental misunderstanding of the nature of the symptoms involved in 

mitochondrial disorders and how such disorders are diagnosed” (id. at *30). She added that 

Petitioners’ presentation of their mitochondrial disorder theory “was highly speculative, poorly 

explained by Dr. Cave, and did not fit the facts of Petitioners’ case.” Id. at *7. The special 
11

master found that Dr. Cave was clearly wrong in asserting that A.H.M. suffered from either a 

“mitochondrial disorder” or a “mitochondrial dysfunction.” Id. at *34-36.

D. The Petitioners’ “Table Injury” claim 

As Special Master Vowell pointed out in her Decision, there are two ways to establish 

entitlement to causation under the Vaccine Act -- either by demonstrating that the vaccinee 

suffered a “Table Injury,” or by demonstrating that one or more vaccines “caused-in-fact” an 

injury to the vaccinee. 2015 WL 5456093, at *36. Less than one month before the hearing in 

this case, Petitioners for the first time raised a claim of “Table Injury encephalopathy,” allegedly 

occurring after the vaccinations of September 1999. 2015 WL 5456093, at *7. After listening to 

their Table Injury claim at the evidentiary hearing, Special Master Vowell found the claim to be 

without merit. Id. at *37-39. She found the claim to be “poorly articulated.” Id. at *37. The 

special master found --

nothing in the record to indicate A.H.M. suffered any reaction to the DTaP and MMR 

vaccines she received on September 15, 1999, much less an encephalopathy as defined in 

the *** Vaccine Injury Table. Certainly, she did not suffer an acute encephalopathy 

within the time periods required by the Vaccine Injury Table. See 42 C.F.R. § 

100.3(a)II.B and III.B.

Id. at *38. 

Further, quite relevantly to this Decision’s ruling concerning “reasonable basis,” Special 

Master Vowell concluded not only that Petitioners’ Table Injury claim was without merit, but 

added that -- “[u]nder the facts of this case, it was unreasonable to maintain that A.H.M. 

experienced a Table encephalopathy.” Id. at *37 (emphasis added). 

E. Petitioners’ “causation-in-fact” claims in general 

I have already discussed above that Special Master Vowell found the “mitochondrial 

disorder” aspect of Petitioners’ “causation-in-fact” claim to be wrong, and reflective of a 

“fundamental misunderstanding” of the science concerning that alleged disorder. 2015 WL 

5456093, at *30. As to other aspect of Petitioners’ two-pronged “causation-in-fact” theory in 

this case, Special Master Vowell again found Petitioners’ claims to be completely unpersuasive. 

Id. at *39-43. The special master listed many defects in Dr. Cave’s presentation. For example, 

Special Master Vowell observed that --

Doctor Cave provided few details about and little support for her theory. The medical 

literature offered by Dr. Cave either did not indicate what she claimed or did not provide 

support for her theories. She referred to oxidative stress on several occasions but failed to 

explain how the vaccines A.H.M. received could have caused oxidative stress sufficient 

to result in the damage she describes. Identifying the “toxins” in the vaccines A.H.M. 

received, Dr. Cave listed monosodium glutamate and heavy metals such as aluminum and 

mercury but sometimes included other components as well as the live virus itself. See, 

e.g., Pet. Ex. 11–a at 10–11. She offered no information regarding the quantities required 

for toxicity, the quantities present in the vaccines, or any reliable evidence that these 
12

amounts could cause mitochondrial dysfunction, impair mitochondrial dysfunction or 

cause ASD to develop.

2015 WL 5456093, at *41 (footnote omitted). The special master also noted that during the 

evidentiary hearing, “Doctor Cave switched with abandon between *** variations of her theory.” 

Id. 

F. Summary comments of Special Master Vowell 

Special Master Vowell summarized that “Petitioners’ hearing presentation and posthearing arguments were not well-developed or presented.” 2015 WL 5456093, at *7. The 

special master found the “content” of Dr. Cave’s opinion and testimony to be “troubling.” Id. at 

*12. She noted inconsistencies in Petitioners’ presentation, noting, for example, that --

[p]recisely how petitioners squared their claim in the petition that A.H.M. suffered a 

progressive decrease in brain function with their claim that A.H.M. improved on 

treatment and now has fewer deficits was never elucidated.

Id. at *6. 

The special master also noted with concern that at the evidentiary hearing Mr. Cave first 

stated that he had talked with Petitioner Kellie Miller on the night before the hearing, but later 

admitted that he had not been in contact with the Petitioners for some months before the hearing. 

2015 WL 5456093, at *5.

Finally, Special Master Vowell also commented that Mr. Cave’s election to utilize his 

mother as his sole expert witness at the evidentiary hearing reflected poorly on the “judgment” of 

Mr. Cave in presenting his clients’ case. 2015 WL 5456093, at *12.

V

DETERMINATION CONCERNING “REASONABLE BASIS”

A. There was a reasonable basis prior to the decision to engage Dr. Cave as the testifying 

expert. 

As set forth above in Section II of this Decision, in the early 2000s major controversies 

arose as to the question of whether autism spectrum disorders might be caused or otherwise 

affected by either MMR vaccines or thimerosal-containing vaccines. Therefore, thousands of 

parents filed Vaccine Act claims during the early 2000s alleging that their children’s ASDs were 

vaccine-caused. I and other special masters have found that these claims were brought in good 

faith. Further, given the scientific uncertainty at the time, I find that the filing of this particular

petition in 2002, along with thousands like it, was reasonable. It was further reasonable to keep 

such claims, including this one, pending until the OAP “test cases” became final in 2010, and for 

some period of time thereafter, in order for counsel to digest the complicated science, and to 

consult with qualified experts to see if a reasonable basis to go forward with the claims could be 
13

found. Accordingly, I will compensate counsel in this case for his reasonable efforts in filing the 

petition, and for his efforts up until the time in 2011 that he chose an unqualified expert, his own 

mother, to become his expert witness. 

B. There was no reasonable basis to pursue this case subsequent to the decision to engage Dr. 

Cave as the testifying expert. 

As demonstrated by the excerpts from Special Master Vowell’s opinion cited above, that 

special master clearly was of the opinion that Petitioners’ counsel and Dr. Cave presented an 

extremely defective case. After reviewing the record of this case myself, I agree with all of 

Special Master Vowell’s comments. I have reviewed Dr. Cave’s expert reports and other filings,

Dr. Cave’s testimony during the evidentiary hearing, and the many filings of Mr. Cave on 

Petitioners’ behalf, including his post-hearing memorandum. I conclude, like Special Master 

Vowell, that Petitioners’ and Dr. Cave’s pre-hearing, hearing, and post-hearing arguments were 

extremely poorly developed and presented -- to the point of being, in essence, frivolous. 

I agree with Special Master Vowell that Dr. Cave, certified in family medicine but 

without any special training or qualifications pertinent to the main issues in this case -- i.e., 

whether a Table Injury encephalopathy took place, whether A.H.M. suffered from a 

mitochondrial disorder, or the causation of autism spectrum disorders -- was unqualified to 

present a persuasive opinion in this case. E.g., 2015 WL 5456093, at *7, *11, *12. 

I agree with Special Master Vowell that the presentations of both Dr. Cave and Mr. Cave 

were based upon a serious misreading and/or a disregard of the medical records pertaining to 

A.H.M. E.g., 2015 WL 5456093, at *24-27, *37. For example, the medical records do not 

support Dr. Cave’s assertion that A.H.M. suffered a “sudden” or “dramatic” reaction after either 

her June 1999 or September 1999 vaccinations. Id. at *25. As the Special Master summarized, 

“Petitioners’ assertions regarding the factual predicate for their claims are *** far removed from 

the facts of this case.” Id. at *37. 

I also agree with Special Master Vowell that Dr. Cave’s testimony about an alleged 

“mitochondrial disorder” in A.H.M. was confused and plainly incorrect. 2015 WL 5456093 at 

*28-36. As that special master concluded, Dr. Cave’s testimony concerning that issue “reflected 

a fundamental misunderstanding of the nature of the symptoms involved in mitochondrial 

disorders and how such disorders are diagnosed.” 2015 WL 5456093, at *30.

Further, I agree with Special Master Vowell that Mr. Cave’s and Dr. Cave’s argument 

that A.H.M. suffered a “Table Injury encephalopathy” was completely contradicted by the 

medical records, and completely devoid of merit. 2015 WL 5456093, at *37-39. The special 

master went so far as to remark that it was “unreasonable” for Mr. Cave and Dr. Cave to argue

that A.H.M. experienced a Table Injury encephalopathy. Id. at *37. 

I also agree with Special Master Vowell that, in addition to Dr. Cave’s misguided 

“mitochondrial disorder” contention mentioned above, the other aspects of Petitioners’

“causation-in-fact” theories were completely unpersuasive. 2015 WL 5456093, at *39-43.

Accordingly, in light of all the gross deficiencies in Petitioners’ case described above, I 

come inevitably to the conclusion that there was no reasonable basis for Petitioners’ counsel to 
14

go forward with this extremely weak case, subsequent to his decision in 2011 to engage Dr. Cave 

as Petitioners’ testifying expert. The only reasonable course for Petitioners’ counsel at that time, 

given the facts in the medical record, and if the only expert that he could obtain was Dr. Cave, 

was either to persuade Petitioners to abandon their claim, or, failing that, to withdraw from the

case. For Mr. Cave to incur the expense of Dr. Cave’s defective reports, then to push this case 

forward to an evidentiary hearing on the basis of theories that were so unpersuasive, and so 

contrary to the actual medical records of A.H.M., was simply not reasonable. 

Adding to the lack of reasonable basis in this case is that prior to 2011, when Mr. Cave 

solicited the report of Dr. Cave, there were several strong indications, of which Mr. Cave was 

aware, that he was retaining an underqualified and unpersuasive expert. For example, in Nilson 

v. HHS, No. 98-797V, 2005 WL 6122524 (Fed. Cl. Spec. Mstr. Aug. 31, 2005), Special Master 

Sweeney (now Judge Sweeney) compared the expert reports and testimony of Dr. Cave and Dr. 

Wiznitzer regarding several disputed issues, and found that Dr. Wiznitzer’s opinion on each was 

more credible. Id. at *17-20. The special master concluded that “[i]n this case, Dr. Cave’s 

theories of causation were effectively rebutted by a highly-credentialed pediatric neurologist, Dr. 

Wiznitzer, whose testimony was far more credible and compelling.” Id. at *20. In Berge v. HHS, 

No. 08-223V, 2010 WL 3431601 (Fed. Cl. Spec. Mstr. Aug. 2, 2010), Special Master Vowell 

dismissed the case largely because of the fact that “Dr. Cave’s expert report being premised upon 

information supplied by the parents, [without discussing] the medical records at all, that opinion 

is rejected as without factual predicate.” Id. at *2 (citation omitted). Thus, in 2010 Dr. Cave was 

made aware of the necessity to substantiate her factual allegations in Vaccine Act cases by citing 

the medical records, but nevertheless, she failed to do so in this case. Thus, the Nilson and Berge 

opinions demonstrate that by 2011 Mr. Cave should have been aware that Dr. Cave was not a 

credible witness for this case.6 

VI

NOTATION CONCERNING “REASONABLE BASIS” IN AUTISM CASES IN 

GENERAL

As discussed above in Section II of this Decision, in the early 2000s controversies arose 

concerning whether autism spectrum disorders might be caused or affected by vaccines. Thus, 

thousands of Vaccine Act claims were filed during those years alleging that ASDs were vaccinecaused. These claims were certainly brought in good faith. Further, in light of the scientific 

uncertainty at the time, I find that the filing of those petitions was reasonable. It was further 

reasonable to keep such claims pending until the OAP “test cases” became final in 2010, and for 

 

6

I also note that in Mooney v. HHS, No. 05-266V, 2014 WL 7715158 (Fed. Cl. Spec. Mstr. 

Dec. 29, 2014), Special Master Vowell declined to award costs for the production of Dr. Cave’s 

expert opinion, awarding only a small amount for “consultation” services, and added that “I am 

unlikely to authorize Dr. Cave’s consultant fees for hearing preparation in any similar cases filed 

by Mr. Cave.” Id. at *14. 
15

some period of time thereafter, in order for counsel for each petitioner to digest the complicated 

science, and to consult with experts to see if a reasonable basis to go forward could be found. 

However, by the end of 2010, the two major theories of vaccine-causation of autism had 

been thoroughly considered and rejected in the OAP test cases, with opinions that, among other 

things, found that all of the many reputable epidemiological studies had found no association

between any vaccines and autism. At that point, the vast majority of the approximately 5,000 

autism petitioners elected either to withdraw their claims, or to request that the special master 

enter a decision denying their claim on the written record. Only a small minority of the autism 

petitioners elected to continue to pursue their cases, seeking other causation theories and/or other 

expert witnesses. Since 2010, a number of such cases have gone to trial before special masters, 

and in the cases of this type decided thus far, all have resulted in rejection of petitioners’ claims 

that vaccines were the cause-in-fact of their children’s ASDs. See the cases cited above in 

Section II. 

There is now, therefore, a serious question concerning whether it is reasonable for 

additional Vaccine Act petitioners to continue to pursue highly speculative theories concerning 

vaccinees with autism spectrum disorders. In each such case, of course, a case-specific decision 

must be made concerning if and when it became unreasonable, under all the circumstances of the 

case, to continue to go forward. In many of the cases since 2010, as in this case, petitioners have 

tried to avoid the conclusions of the test cases by alleging that a child suffered a vaccine-caused 

“encephalopathy” that resulted in “autistic-like features,” or that a child had an underlying 

“mitochondrial disorder” that somehow made the child more vulnerable to injuries by vaccines. 

But such cases, in essence, have amounted to attempts to prove that vaccines can cause or 

aggravate symptoms of ASDs. And, except for the two highly unusual Table Injury cases 

described at footnote 4 above, all such theories have been rejected. 

Further, a review of the post-test case decisions enumerated in Section II above 

demonstrates that those cases typically involved expert witnesses who were quite underqualified 

to opine on the vaccine-causation issues at hand, and/or presented theories with no substantial 

scientific merit, and/or disregarded the facts contained in the medical records of the case. 

Accordingly, I hereby put counsel, especially in autism-related cases, on notice, once 

again, that if counsel continue to go forward with such extremely weak cases, I am not likely to 

find that there was a reasonable basis for their continued prosecution of the case.

VII

CALCULATIONS OF FEES AND COSTS AWARDED

1. Attorney’s hourly rates

Attorney Cave has practiced law since 1999. In this case, he seeks compensation at the 

hourly rates of $161 for attorney services performed in 2002; $165 for 2003; $169 for 2004; 

$175 for 2005; $181 for 2006; $186 for 2007; $193 for 2008; $248 for 2009; $253 for 2010; 

$261 for 2011; and higher amounts for 2012 to 2015. (ECF No. 84-2.) The rates for 2006 –
16

2011 are the same as or quite similar to the rates that Special Master Vowell granted to him for 

those years in the case of Mooney v. HHS, 2014 WL 7715158, at *9. I find those claimed rates 

to be reasonable. I will compensate Mr. Cave at his claimed rates from 2002 through 2011. 

2. Attorney hours in general

I find reasonable the number of hours Mr. Cave billed for 2002 through 2010, for the reasons 

set forth above. As to the hours billed for 2011, I will compensate Mr. Cave for the hours billed 

from the beginning of that year through May 31, 2011. Based on Mr. Cave’s billing records, 

however, it appears that about that time Mr. Cave solicited an expert report from Dr. Cave, 

which he “reviewed” on July 15, 2011. (ECF No. 84-4, p. 2.) I will not compensate Mr. Cave 

for the hours after May 31, 2011, for the reasons cited above -- i.e., as explained, I find no 

reasonable basis for Mr. Cave to solicit an expert report from Dr. Cave, and I find no reasonable 

basis for the claim for Vaccine Act compensation that Mr. Cave and Dr. Cave put forward after 

that time. 

3. Summary of attorney hours

Utilizing Mr. Cave’s summary in his fees application (ECF No. 84-4, p. 9), I award him the 

fees requested for 2002 through 2010, which total $3,440.02. For 2011, I award him fees for the 

hours claimed through May 31, 2011. (3.66 hours times $261 per hour = $956.82.) 

4. Costs

Of the costs claimed at ECF No. 84-4, p. 9, I allow only the $150 for the filing fee paid in 

2002. I deny the other costs claimed on that page, as they were all incurred during 2012. (ECF 

No. 84-4, pp. 13-20.) I also deny all costs claimed at ECF No. 84-4, p. 10, consisting of $25,443 

paid to Dr. Cave, plus the costs of the evidentiary hearing. 

5. Summary

As explained above, I award Petitioners $150 in costs, $3,440.02 for Mr. Cave’s services in 

2002-2010, and $956.82 for Mr. Cave’s services in January through May of 2011, for a total 

award of $4,546.84. 

VIII

CONCLUSION

 For the foregoing reasons, I award Petitioners $4,546.84 in attorneys’ fees and costs. The 

$4,546.84 award shall be made in the form of a check payable jointly to Petitioners and 

Petitioners’ counsel. The Clerk of this Court shall enter judgment accordingly. 
17

IT IS SO ORDERED.

 /s/ George L. Hastings, Jr.

George L. Hastings, Jr.

Special Master